echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: Prevention of morbidity and mortality after aneurysmal subarachnoid hemorrhage

    Stroke: Prevention of morbidity and mortality after aneurysmal subarachnoid hemorrhage

    • Last Update: 2022-04-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Aneurysmal subarachnoid hemorrhage is associated with high mortality and morbidity


    Vascular prevention

    As of February 2020, researchers searched Medline, Web of Science, Embase, Scopus, ProQuest and CochraneCentral


    Eligible trials compared the preventive effect of any oral or intravenous drug or intracranial drug-eluting implant, or placebo or standard care in hospitalized patients with confirmed aneurysmal subarachnoid hemorrhage


    The researchers included 53 trials involving a total of 10,415 patients


    CONCLUSIONS: Nimodipine and cilostazol may be the most effective treatments for preventing morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage


    Nimodipine and cilostazol may be the most effective treatments for preventing morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage


    Original source:

    Mojtaba Dayyani.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.